Brazil vs Malawi: Number of people at risk of trachoma and those receiving treatment
Brazil
0 People
in 2024
Malawi
0 People
in 2024
Brazil rank
26th
Malawi rank
26th
Number of people at risk of trachoma and those receiving treatment over time
- Brazil
- Malawi
How they compare
Brazil currently reports 0 People against 0 People in Malawi, a difference of 0 People.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was Malawi ahead.
Brazil ranks 26th and Malawi ranks 26th of 57 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.94 million People | 3.66 million People | 1.28 million People | Brazil |
| 2020s | 3.09 million People | 0 People | 3.09 million People | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people at risk of trachoma and those receiving treatment, Brazil or Malawi?
- Brazil, at 0 People against 0 People in Malawi as of 2024.
- What is the difference in number of people at risk of trachoma and those receiving treatment between Brazil and Malawi?
- 0 People, with Brazil ahead.
- How many years of comparable data are there for Brazil and Malawi?
- 11 years are reported by both, from 2014 to 2024.
- How do Brazil and Malawi rank globally for number of people at risk of trachoma and those receiving treatment?
- Brazil ranks 26th and Malawi ranks 26th of 57 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Number of people at risk of trachoma and those receiving treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated number of people living in areas where trachoma is common ('at risk population'), and the number of people who have been treated with antibiotics or surgery.